1-2 of 2
Patrick Auberger
Close
Sort by
Journal Articles

Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity

Clinical Trials & Observations
Johan Courjon, Océane Dufies, Alexandre Robert, Laurent Bailly, Cédric Torre, David Chirio, Julie Contenti, Sébastien Vitale, Céline Loubatier, Anne Doye, Christelle Pomares-Estran, Géraldine Gonfrier, Romain Lotte, Patrick Munro, Orane Visvikis, Jean Dellamonica, Valérie Giordanengo, Michel Carles, Laurent Yvan-Charvet, Stoyan Ivanov, Patrick Auberger, Arnaud Jacquel, Laurent Boyer
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1523–1534.
https://doi.org/10.1182/bloodadvances.2020003918
Published: 2021
Includes: Supplemental data
Journal Articles

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Clinical Trials & Observations
Edmond Chiche, Ramy Rahmé, Sarah Bertoli, Pierre-Yves Dumas, Jean-Baptiste Micol, Yosr Hicheri, Florence Pasquier, Pierre Peterlin, Patrice Chevallier, Xavier Thomas, Michael Loschi, Alexis Genthon, Ollivier Legrand, Mohamad Mohty, Emmanuel Raffoux, Patrick Auberger, Alexis Caulier, Magalie Joris, Caroline Bonmati, Gabrielle Roth-Guepin, Caroline Lejeune, Arnaud Pigneux, Norbert Vey, Christian Recher, Lionel Ades, Thomas Cluzeau
Journal: Blood Advances
Blood Adv (2021) 5 (1): 176–184.
https://doi.org/10.1182/bloodadvances.2020003159
Published: 2021
Includes: Supplemental data